Product
Drug treatment of myasthenia gravis
1 clinical trial
11 indications
Indication
Myasthenia GravisIndication
Neuromuscular Junction DiseasesIndication
ThymomaIndication
Thymus HyperplasiaIndication
Nervous System DiseasesIndication
GeneralizedIndication
OcularIndication
Myasthenia Gravis CrisisIndication
Adult FormIndication
Juvenile Myelomonocytic LeukemiaClinical trial
Predictors and Prognostic Factors of Myasthenia Gravis OutcomeStatus: Recruiting, Estimated PCD: 2024-06-30